Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients

• Main Authors: Felisiak-Golabek Anna (Author), Rembiszewska Alina (Author), Rzepecka Iwona K (Author), Szafron Lukasz (Author), Madry Radoslaw (Author), Murawska Magdalena (Author), Napiorkowski Tomasz (Author), Sobiczewski Piotr (Author), Osuch Beata (Author), Kupryjanczyk Jolanta (Author)
• Format: Book
• Published: BMC, 2011-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of survivin expression in...